[Prospects of use coryneformic bacteria drug to prevent and treat respiratory infections].
This work shows the Codivac efficiency in its aerosol form to treat children sick of influenza and acute respiratory viral infections. Course of therapy with the Codivac drug leads to improve clinical picture and rapid elimination virus from human organism as compared with children undergone traditional therapy. Recovery is accompanied with improving of indices of cell immunity. The article shows the prospects of use Codivac to prevent and treat respiratory infections.
Shmeleva
E A
EA
Vartanian
R V
RV
Aleshkin
V A
VA
Paramonova
Iu Aq
IuA
Baturina
i G
iG
Malyshev
N A
NA
D000192:Actinomycetales / Q000502:physiology*; D000208:Acute Disease; D000280:Administration, Inhalation; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004168:Diphtheria Toxoid / Q000494:pharmacology* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005544:Forecasting; D006801:Humans; D007223:Infant; D008829:Microbiology / Q000639:trends*; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000187:drug effects; D013997:Time Factors
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; C069433:Codivac; D004168:Diphtheria Toxoid